Pharmaceutical Business review

Allocade names new CEO

Mr Smith, who brings more than 25 years of experience in leading global sales and marketing organizations for healthcare companies, also serves on Allocade’s board of directors.

Prior to joining Allocade, Mr Smith has spent more than 14 years serving in various senior management positions at both Siemens Medical Systems and Acuson.

Mr Smith holds a bachelors degree in education from Western Illinois University and a masters degree in education from Southern Illinois University.

Henry Wilder, board director of Allocade, said: “Rick has extensive experience in creating and building healthcare companies into world class solution providers. With Rick’s proven track record in the industry and his depth of knowledge, we have a powerful team in place to maximize Allocade’s growth and leadership.”